Your browser doesn't support javascript.
loading
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
Fedele, Pasquale L; Gregory, Gareth P; Gilbertson, Michael; Shortt, Jake; Kumar, Beena; Opat, Stephen; Grigoriadis, George.
Afiliação
  • Fedele PL; Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168. pasquale.fedele@monashhealth.org.
  • Gregory GP; Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. pasquale.fedele@monashhealth.org.
  • Gilbertson M; Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.
  • Shortt J; Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.
  • Kumar B; Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.
  • Opat S; School of Clinical Sciences at Monash Health, Faculty of Medicine, Dentistry and Health Sciences, Monash University, Clayton, Australia.
  • Grigoriadis G; Pathology Department, Monash Medical Centre, Clayton, Australia.
Ann Hematol ; 95(4): 667-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26801792
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Infusões Subcutâneas / Linfoma Plasmablástico / Bortezomib Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Infusões Subcutâneas / Linfoma Plasmablástico / Bortezomib Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article